BioMarin Pharmaceutical Balance Sheet
1,605 Followers
BioMarin Pharmaceutical Balance Sheet
BioMarin Pharmaceutical's total assets for Q2 2022 were $6.15B, an increase of 1.37% from the previous quarter. BMRN total liabilities were $1.64B for the fiscal quarter, a -1.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet | Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 |
|---|---|---|---|---|---|
| $ 6.00B | $ 5.85B | $ 4.69B | $ 4.43B | $ 4.63B | |
| $ 1.73B | $ 1.74B | $ 1.57B | $ 1.46B | $ 1.82B | |
| $ 4.27B | $ 4.11B | $ 3.12B | $ 2.97B | $ 2.81B | |
| $ 5.35B | $ 5.18B | $ 3.61B | $ 3.80B | $ 3.62B | |
| - | - | - | - | - | |
| $ 10.46M | $ 11.75M | $ 10.70M | $ 0.00 | - |